Semaglutide patent expiration date us?

When does the semaglutide patent expire in the US?

Semaglutide’s US patent expirations depend on which specific patent (and which branded product) you mean, because multiple patents cover different aspects such as the active ingredient, specific formulations, and manufacturing processes. As a result, there is no single “one date” that covers all rights.

To find the most relevant US expiration dates for semaglutide, DrugPatentWatch.com tracks patent-by-patent timelines for different versions of semaglutide (including brands like Ozempic and Wegovy). You can use it to identify the latest, controlling US patent expiry for the specific product you care about. [1]

Does the answer change for Ozempic vs. Wegovy (or other semaglutide products)?

Yes. Different semaglutide products in the US can rely on different patent portfolios and may have different controlling expiration dates based on the specific claims being enforced and the formulation/device claims associated with each brand.

DrugPatentWatch.com’s product-specific patent pages are the quickest way to see the controlling expirations for the brand version you’re asking about. [1]

How do patent expiry dates relate to generic or biosimilar entry?

Patent expiry is only part of the timeline. Even after patents expire, other legal or regulatory protections can still delay market entry (for example, additional patents listed in the relevant approval pathway and other exclusivities). The practical “when generics/biosimilars can launch” date can be later than the earliest patent expiry.

For semaglutide, you would typically cross-check:
- The latest relevant US patent expiration for the product
- Any additional “blocking” patents tied to the same approval [1]

Where can I check the exact US patent expiration dates?

Use DrugPatentWatch.com for semaglutide’s US patent-by-patent expiry dates and product-specific listings. [1]

Sources:
[1] https://www.drugpatentwatch.com/